1 |
Rhyu MR, Kim DK, Kim HY, Kim BK. 2000. Nitric oxidemediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with Monascus ruber. J Ethnopharm 70: 29-34.
과학기술학회마을
DOI
ScienceOn
|
2 |
Endo A. 1985. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMGCoA reductase. J Medicinal Chem 28: 401-405.
DOI
|
3 |
Rhyu MR, Kim EY. 2002. The relation between antihypertensive effect and -aminobutyric acid, mycelial weight and pigment of Monascus. Kor J Food Sci Technol 34: 737-740.
과학기술학회마을
|
4 |
Endo A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiotics 32: 852-854.
DOI
|
5 |
Tsuji K, Ichikawa T, Tanabe N, Abe S, Tarui S, Nakagawa Y. 1992. Antihypertensive activities of beni-koji extracts and -aminobutyric acid in spontaneously hyeprtensive rats. Jpn J Nutr 50: 285-291.
DOI
|
6 |
Endo A. 1985. Trends in Monascus koji and Monascus strains. Hako To Kogyo 43: 544-552.
|
7 |
Endo A. 1979. Monacolin, a new hypocholesterolemic agent produced by a Monascus species. J Antibiotics 3: 852-854.
|
8 |
Rhyu MR, Kim EY, Han JS. 2002. Antihypertensive effect of the soybean paste fermented with the fungus Monascus. Int J Food Sci Technol 37: 585-588.
DOI
ScienceOn
|
9 |
Rhyu MR, Kim EY, Kim HY, Ahn BH, Yang CB. 2000. Characteristics of the red rice fermented with fungus Monascus. Food Sci Biotechnol 9: 21-26.
과학기술학회마을
|
10 |
Tsuji K, Ichikawa T, Tanabe N, Abe S, Tarui S, Nakagawa Y. 1992. Effects of two kinds of koji on blood pressure in spontaneously hypertensive rats. Nippon Nogeikagaku Kaishi 66: 1241-1246.
DOI
ScienceOn
|
11 |
Kroon PA, Hand KM, Huff JW, Alberts AW. 1982. The effect of mevinolin on serum cholesterol levels of rabbits with endogenous hypercholesterolemia. Atherosclerosis 44: 41-48.
DOI
ScienceOn
|
12 |
SAS Institute Inc. 1985. SAS User's Guide. Cary, NC, USA.
|
13 |
American Institute of Nutrition. 1977. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies J Nutr 107: 1340-1348.
DOI
|
14 |
Arad Y, Ramakrishnan R, Ginsberg HN. 1990. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res 31: 567-582.
|
15 |
Endo A. 1980. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Antibiotics 3: 334-336.
|
16 |
Tsuji K, Ichikawa T, Tanabe N, Obata H, Abe S, Tarui S, Nakagawa Y. 1992. Effect of mycelial weight on hypotensive activity of beni-koji in spontaneously hypertensive rats. Nippon Shokuhin Kogyo Gakkaishi 39: 790-795.
DOI
|
17 |
Rader DJ, Davidson MH, Caplan RJ, Pears JS. 2003. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. Am J Cardiol 91(suppl): 20C-24C
DOI
ScienceOn
|